BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6089324)

  • 1. Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition.
    Aurell M
    Scand J Urol Nephrol Suppl; 1984; 79():9-12. PubMed ID: 6089324
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
    Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease.
    Mancia G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Grassi G
    J Hypertens Suppl; 2006 Mar; 24(1):S51-6. PubMed ID: 16601574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interactions between the renin-angiotensin-aldosterone system and sympathetic neurotransmission].
    Villalón CM; Terrón JA; Ramírez-San Juan E; Saxena PR
    Arch Inst Cardiol Mex; 1995; 65(1):89-94. PubMed ID: 7639602
    [No Abstract]   [Full Text] [Related]  

  • 8. New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy.
    Batlle D; Soler MJ; Wysocki J
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):250-7. PubMed ID: 18408475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New evidence for brain angiotensin and for its role in hypertension.
    Phillips MI
    Fed Proc; 1983 Jul; 42(10):2667-72. PubMed ID: 6305729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiotensin I converting enzyme.
    Erdös EG
    Fed Proc; 1977 Apr; 36(5):1760-5. PubMed ID: 191298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin I converting enzyme--properties, functions and methods of analysis].
    Siems WE; Halle W
    Pharmazie; 1982 Aug; 37(8):539-44. PubMed ID: 6292961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
    Schunkert H; Holmer SR; Riegger G
    Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and pharmacology of angiotensin converting enzyme inhibitors.
    Antonaccio MJ
    J Pharmacol; 1983; 14 Suppl 3():29-45. PubMed ID: 6323887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of inhibitors of the renin-angiotensin system.
    Fouad-Tarazi FM
    J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant hypertension - the role of the paracrine renin-angiotensin system.
    Fleming S
    J Pathol; 2000 Oct; 192(2):135-9. PubMed ID: 11004688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin II and of angiotensin converting enzyme inhibition in chronic renal failure.
    Ledingham JG
    Kidney Int Suppl; 1987 May; 20():S112-6. PubMed ID: 3037159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renin-angiotensin system: current view].
    del Río A
    Med Clin (Barc); 1991 Jun; 97(1):17-20. PubMed ID: 1649939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.